Beta
303331

Synergistic Effect of Biogenic Silver Nanoparticles and Antibiotics Against Multidrug-Resistant Pseudomonas aeruginosa

Article

Last updated: 03 Jan 2025

Subjects

-

Tags

-

Abstract

Infections caused by Pseudomonas aeruginosa may be either acquired in the community or contracted in a healthcare setting. Multidrug-resistant (MDR) P. aeruginosa is a growing problem; a new treatment approach is required to tackle this. Combination therapy of antibiotics and nanoparticle is thus applied to overcome this problem. Therefore, this study was planned to evaluate the synergistic effect of AgNPs along with different antibiotics against MDR P. aeruginosa. A total of 120 surgical or burn wound samples were collected from a tertiary care hospital. The plates containing the samples cultivated on cetrimide agar were then heated to 37°C. Isolates were identified based on colony shape, Gram staining, and several biochemical tests. A Kirby-Bauer disc diffusion technique antibiogram was conducted following CLSI 2022 recommendations. A minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were also determined. The Agar well diffusion technique and the microdilution method were used to test the antibacterial activity of the AgNPs, respectively. The synergistic effect of antibiotics and AgNPs was estimated by the Checkerboard method. Out of 120 samples, 46 (38.8%) were confirmed positive for P. aeruginosa, and out of that, 33 were confirmed as MDR P. aeruginosa. Seven representative isolates proceeded for further procedures. Antibacterial activity of AgNPs revealed a maximum zone of inhibition of 12 mm at 4 mg/ml and a minimum of 2.5 mm at 1 mg/ml by agar well diffusion method. MIC and MBC of AgNPs showed that all the isolates were inhibited at 250 mg/ml. The FIC index of checkerboard results showed that colistin and gentamicin exhibited complete synergism with AgNPs, while ciprofloxacin showed partial synergism with AgNPs.

DOI

10.21608/eajbsc.2023.303331

Keywords

Carbapenemase, P. aeruginosa, modified carbapenem inactivation method, sensitivity, specificity, Kirby Bauer Disc Diffusion Method

Authors

First Name

Naif

Last Name

Jalal

MiddleName

A.

Affiliation

Department of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah Saudi Arabia.

Email

-

City

Saudi Arabia

Orcid

-

First Name

Sumyya

Last Name

Hariri

MiddleName

H.

Affiliation

Department of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah Saudi Arabia.

Email

-

City

Saudi Arabia

Orcid

-

First Name

Noha

Last Name

Abdel-razik

MiddleName

E.

Affiliation

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Gizan, Saudi Arabia.

Email

-

City

Saudi Arabia

Orcid

-

First Name

Abdulrahman

Last Name

Alzahrani

MiddleName

-

Affiliation

Department of Applied Medical Sciences, Applied College, Al-Baha University, Al-Baha, Saudi Arabia.

Email

-

City

Saudi Arabia

Orcid

-

First Name

Suleman

Last Name

Khan

MiddleName

-

Affiliation

Department of Agricultural Sciences, Food, Natural Resources and Engineering, Università degli Studi di Foggia, Italy.

Email

sulemankhanazmat333@gmail.com

City

Italy

Orcid

-

First Name

Farkad

Last Name

Bantun

MiddleName

-

Affiliation

Department of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah Saudi Arabia.

Email

-

City

Saudi Arabia

Orcid

-

Volume

15

Article Issue

1

Related Issue

38909

Issue Date

2023-06-01

Receive Date

2023-01-24

Publish Date

2023-04-01

Page Start

319

Page End

337

Print ISSN

2090-0767

Online ISSN

2090-083X

Link

https://eajbsc.journals.ekb.eg/article_303331.html

Detail API

https://eajbsc.journals.ekb.eg/service?article_code=303331

Order

303,331

Type

Original Article

Type Code

673

Publication Type

Journal

Publication Title

Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology

Publication Link

https://eajbsc.journals.ekb.eg/

MainTitle

Synergistic Effect of Biogenic Silver Nanoparticles and Antibiotics Against Multidrug-Resistant Pseudomonas aeruginosa

Details

Type

Article

Created At

24 Dec 2024